| Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination J Yu, MD Green, S Li, Y Sun, SN Journey, JE Choi, SM Rizvi, A Qin, ... Nature medicine 27 (1), 152-164, 2021 | 530 | 2021 |
| Cancer SLC43A2 alters T cell methionine metabolism and histone methylation Y Bian, W Li, DM Kremer, P Sajjakulnukit, S Li, J Crespo, ZC Nwosu, ... Nature 585 (7824), 277-282, 2020 | 326 | 2020 |
| CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4 P Liao, W Wang, W Wang, I Kryczek, X Li, Y Bian, A Sell, S Wei, S Grove, ... Cancer cell 40 (4), 365-378. e6, 2022 | 304 | 2022 |
| A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control Z Sun, Z Ren, K Yang, Z Liu, S Cao, S Deng, L Xu, Y Liang, J Guo, Y Bian, ... Nature communications 10 (1), 3874, 2019 | 161 | 2019 |
| Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B W Wang, X Zhou, Y Bian, S Wang, Q Chai, Z Guo, Z Wang, P Zhu, H Peng, ... Nature nanotechnology 15 (5), 406-416, 2020 | 148 | 2020 |
| Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance H Lin, I Kryczek, S Li, MD Green, A Ali, R Hamasha, S Wei, L Vatan, ... Cancer Cell 39 (4), 480-493. e6, 2021 | 89 | 2021 |
| Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance Y Liang, H Tang, J Guo, X Qiu, Z Yang, Z Ren, Z Sun, Y Bian, L Xu, H Xu, ... Nature communications 9 (1), 4586, 2018 | 78 | 2018 |
| Clearing persistent extracellular antigen of hepatitis B virus: an immunomodulatory strategy to reverse tolerance for an effective therapeutic vaccination D Zhu, L Liu, D Yang, S Fu, Y Bian, Z Sun, J He, L Su, L Zhang, H Peng, ... The Journal of Immunology 196 (7), 3079-3087, 2016 | 73 | 2016 |
| Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis H Xia, S Li, X Li, W Wang, Y Bian, S Wei, S Grove, W Wang, L Vatan, ... JCI insight 5 (18), 2020 | 65 | 2020 |
| Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice Y Bian, Z Zhang, Z Sun, J Zhao, D Zhu, Y Wang, S Fu, J Guo, L Liu, L Su, ... Hepatology 66 (4), 1067-1082, 2017 | 65 | 2017 |
| Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control Z Sun, Z Ren, K Yang, Z Liu, S Cao, S Deng, L Xu, Y Liang, J Guo, Y Bian, ... Nature communications 11 (1), 1716, 2020 | 3 | 2020 |
| TUMOR CELLS DEPLETE METHIONINE VIA SLC43A2, CAUSING T-CELL DYSFUNCTION Y Bian, W Li, DM Kremer, P Sajjakulnukit, S Li, J Crespo CANCER DISCOVERY 10 (11), 1623-1623, 2020 | | 2020 |
| PreS1 is used to prepare hepatitis B vaccine and treats the purposes of chronic hepatitis B YX Fu, Y Bian, H Peng CN Patent CN106,421,774 B, 2019 | | 2019 |
| neW Method enAbLes deVeLoPMent of custoMiZed VAscuLAture in orgAnoids Y Bian, W Li, DM Kremer, P Sajjakulnukit, S Li, J Crespo | | |
